TLE3 as a candidate biomarker of response to taxane therapy.
Kulkarni SA, Hicks DG, Watroba NL, Murekeyisoni C, Hwang H, Khoury T, Beck RA, Ring BZ, Estopinal NC, Schreeder MT, Seitz RS, Ross DT.
Kulkarni SA, et al. Among authors: ring bz.
Breast Cancer Res. 2009;11(2):R17. doi: 10.1186/bcr2241. Epub 2009 Mar 23.
Breast Cancer Res. 2009.
PMID: 19309506
Free PMC article.